Search Jaypirca (type in keywords)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Jaypirca ® (pirtobrutinib) tablets
50 mg,100 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Has Jaypirca™ (pirtobrutinib) been studied in pediatric patients?
The safety and effectiveness of Jaypirca (pirtobrutinib) have not been established in pediatric patients.
cFAQ
cFAQ
US_cFAQ_PIR031_PEDIATRIC
en-US
Pirtobrutinib Use in Pediatric Patients
The safety and effectiveness of pirtobrutinib have not been established in pediatric patients.1
Enclosed Prescribing Information
Reference
1Jaypirca [package insert]. Indianapolis, IN: Eli Lilly and Company; 2023.
Date of Last Review: January 09, 2023
Are you satisfied with this content?